Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care.
Taramasso L, Magnasco L, Portunato F, Briano F, Vena A, Giacobbe DR, Dentone C, Robba C, Ball L, Loconte M, Patroniti N, Frisoni P, D'Angelo R, Dettori S, Mikulska M, Pelosi P, Bassetti M. Taramasso L, et al. Eur J Intern Med. 2021 Dec;94:39-44. doi: 10.1016/j.ejim.2021.08.020. Epub 2021 Aug 30. Eur J Intern Med. 2021. PMID: 34511338 Free PMC article.
Will new antimicrobials overcome resistance among Gram-negatives?
Bassetti M, Ginocchio F, Mikulska M, Taramasso L, Giacobbe DR. Bassetti M, et al. Among authors: taramasso l. Expert Rev Anti Infect Ther. 2011 Oct;9(10):909-22. doi: 10.1586/eri.11.107. Expert Rev Anti Infect Ther. 2011. PMID: 21973303 Review.
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project.
Bagella P, Squillace N, Ricci E, Gulminetti R, De Socio GV, Taramasso L, Pellicanò G, Menzaghi B, Celesia BM, Dentone C, Orofino G, Bonfanti P, Madeddu G. Bagella P, et al. Among authors: taramasso l. Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019. Infect Drug Resist. 2019. PMID: 31213857 Free PMC article.
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA).
Taramasso L, Ricci E, Cascio A, Valsecchi L, Menzaghi B, Squillace N, Maggi P, De Socio GV, Dentone C, Madeddu G, Pellicanò GF, Calza L, Angioni G, Bonfanti P, Di Biagio A; CISAI Study Group. Taramasso L, et al. AIDS Res Ther. 2019 Aug 26;16(1):21. doi: 10.1186/s12981-019-0236-0. AIDS Res Ther. 2019. PMID: 31451115 Free PMC article.
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia.
Taramasso L, Di Biagio A, Riccardi N, Briano F, Di Filippo E, Comi L, Mora S, Giacomini M, Gori A, Maggiolo F. Taramasso L, et al. PLoS One. 2019 Oct 11;14(10):e0223181. doi: 10.1371/journal.pone.0223181. eCollection 2019. PLoS One. 2019. PMID: 31603906 Free PMC article.
156 results